To Screen for Scarring Without a Procedure
Noninvasive tests are preferred for staging fibrosis, and a liver biopsy is kept for unclear cases. A score built from a scale, a blood panel, and your history is one of the simplest ways to start.
AI Summary The BARD score combines body mass index, the AST/ALT enzyme ratio, and diabetes status to estimate the risk of liver scarring (fibrosis) in people with fatty liver disease. It needs no scan or procedure. A lower score makes advanced fibrosis less likely, while a higher score usually leads to a second test, such as elastography or the ELF blood test. It cannot diagnose fibrosis or MASH. Next steps include follow-up testing, healthy habits, and specialist care.
Source: www.liverdirectory.com
Medically Reviewed.
The BARD score is a calculation that combines three everyday measures: body mass index (BMI), the ratio of two liver enzymes (AST and ALT), and whether you have diabetes. Doctors use it to estimate the chance of liver scarring, called fibrosis, in people with fatty liver disease.
It needs no scan and no procedure. It is a risk estimate, not a diagnosis. Your care team reads it alongside your other results and may suggest more testing.
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
UNDERSTANDING LIVER FIBROSIS RISK
The BARD score is a noninvasive score that estimates how likely it is that your liver has fibrosis, or scar tissue. The name comes from its three parts: BMI, AST/ALT Ratio, and Diabetes.
Doctors use it in people with fatty liver disease. The current medical name is metabolic dysfunction-associated steatotic liver disease (MASLD). You may also see NAFLD, the older name. In MASLD, extra fat builds up in the liver. A more serious form, metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH), adds inflammation, tissue damage, and scarring.
Fat alone often causes little harm. Scarring is what doctors most want to catch early. The BARD score helps them decide who may need a closer look.
AST and ALT are liver enzymes that rise when liver cells are injured. BARD does not measure liver fat directly. It is one of several MAFLD / MASH scores.
BARD SCORE USES AND PURPOSE
The BARD score answers one question: how likely is it that fatty liver disease has caused scarring? It is a triage tool, not an everyday liver test.
Noninvasive tests are preferred for staging fibrosis, and a liver biopsy is kept for unclear cases. A score built from a scale, a blood panel, and your history is one of the simplest ways to start.
These tools help find people at risk for advanced liver disease who may need a specialist referral or close monitoring. People with obesity, type 2 diabetes, or high cholesterol are the ones most often scored.
A low score may mean no further testing is needed right now. A higher score usually leads to a second test, such as elastography (a liver stiffness scan) or a blood test like the ELF score.
BARD SCORE INPUTS EXPLAINED
Each letter in BARD stands for one input. Your care team takes them from your chart, your BMI, and routine blood work.
All three inputs are already part of routine care, so the score needs no extra procedure.
Your care team can tell you how your own result was worked out and how it fits with your other tests.
INTERPRETING YOUR SCORE
Like other fibrosis scores, BARD sorts people by risk. It does not give a diagnosis.
A lower score suggests advanced fibrosis is less likely. Blood-based scores tend to be most reliable for ruling out advanced fibrosis, so a low result can mean you do not need urgent extra testing. Your doctor may still suggest healthy habits and regular follow-up.
A higher score suggests advanced fibrosis is more likely. It does not confirm scarring. It usually means your doctor will suggest a second test, such as elastography or the ELF blood test, and may refer you to a liver specialist.
Scores are less reliable at confirming scarring than at ruling it out. When results conflict or stay unclear, doctors can use another noninvasive test. A liver biopsy is considered when noninvasive results are ambiguous.
Scoring cutoffs can differ between sources. Ask your care team which cutoff they use and what it means for your next step.
FIBROSIS SCORE LIMITATIONS
BARD estimates risk. Histology from a liver biopsy remains the gold standard for diagnosing MASH, the inflamed form of fatty liver. Your doctor combines imaging, lab tests, and your history.
BARD uses BMI, enzymes, and diabetes status as indirect clues. Tests such as [elastography](/liver-tests/imaging-non-invasive-testing/elastography-fibrosis-testing) measure liver stiffness directly, and MRI-based tests measure liver fat.
Scores such as FIB-4 and the NAFLD fibrosis score are most accurate at separating advanced fibrosis from non-advanced fibrosis. They perform poorly at identifying earlier stages of significant fibrosis. Ask your doctor how that applies to your BARD result.
FIBROSIS TEST COMPARISON
Several tests estimate scarring. They use different inputs, and doctors often use more than one.
| Test | What it uses | Type |
|---|---|---|
| BARD score | BMI, AST/ALT ratio, diabetes | Calculated score, no procedure |
| FIB-4 | Age, AST, ALT, platelet count | Blood-based score |
| APRI | AST and platelet count | Blood-based score |
| ELF score | Hyaluronic acid, PIIINP, TIMP-1 | Blood test |
| Elastography (FibroScan) | Ultrasound-based liver stiffness | Imaging test |
| FAST score | FibroScan stiffness, FibroScan fat measure (CAP), AST | Score that combines imaging and blood |
FATTY LIVER FOLLOW-UP CARE
Your score is a starting point. These steps help you use it well.
Ask whether you need a second test, such as elastography or the ELF blood test, and when to repeat your labs. Bring a list of your medicines and your diabetes history.
Lifestyle change is the foundation of fatty liver care. Weight loss of 3 to 5% can improve liver fat, and more than 10% is often needed to improve inflammation and scarring. A Mediterranean-style diet and regular exercise help too, even without weight loss.
Medicines are mainly for people with biopsy-proven MASH or advanced fibrosis, and bariatric surgery may suit people who meet standard criteria. Your specialist can explain which options fit you.
A hepatologist can review your results, order further tests, and plan care. Use the search below to find one near you.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore liver dietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
BARD stands for BMI, AST/ALT ratio, and Diabetes. These three inputs are combined into one score that estimates the risk of liver scarring (fibrosis) in people with fatty liver disease. BMI compares your weight with your height. AST and ALT are liver enzymes, and their ratio comes from a standard blood test. Diabetes status comes from your medical history. Your doctor uses the result to decide who may need a closer look, not to make a diagnosis.
No. The BARD score estimates risk and helps your doctor choose the next step. It cannot diagnose fibrosis or MASH. Noninvasive tests are preferred for staging fibrosis, and a liver biopsy is kept for unclear cases. Histology from a biopsy remains the gold standard for diagnosing MASH. In practice, your doctor combines your score with imaging, other lab tests, and your history.
Not always. A low score suggests advanced scarring is less likely, but it does not rule out every problem. Blood-based scores are most reliable at ruling out advanced fibrosis. Scores like this perform poorly at identifying earlier stages of significant fibrosis. BARD also does not measure liver fat directly. Keep up with regular checkups and healthy habits, and ask your doctor how often to repeat your labs.
No. A high score means advanced fibrosis is more likely and that more testing is wise. It does not confirm scarring. Cirrhosis is severe, permanent scarring, and a risk score cannot show that on its own. Blood-based scores are weaker at confirming scarring than at ruling it out. Your doctor will usually order a second test, such as elastography or the ELF blood test, and may refer you to a liver specialist.
No special procedure is needed. The score needs no scan and no biopsy. It uses your BMI, routine blood results (AST and ALT), and your diabetes status from your medical history. If your blood draw is ordered with other tests, there may be preparation for those tests. Ask your care team whether your blood draw has any preparation.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.